SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Gerald Abel/Bass Photo Co.

141

Eli Lilly

LLY

The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.

CEO

David A. Ricks

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Indianapolis, IN

Years on Fortune 500 List

22

Employees

41,275

Key Financials (last fiscal year)
$ millions% change
Revenues ($M)$19,9591.7%
Profits ($M)$2,4080.7%
Assets ($M)$35,569
Total Stockholder Equity ($M)$14,571
Market Value — as of March 31, 2016 ($M)$79,535
Profit Ratios
Profit as % of Revenues12.1%
Profits as % of Assets6.8%
Profits as % of Stockholder Equity16.5%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)2.26
EPS % Change (from 2014)1.3%
EPS % Change (5 year annual rate)-13.2%
EPS % Change (10 year annual rate)2.2%
Total Return
Total Return to Investors (2015)25.3%
Total Return to Investors (5 year, annualized)23.8%
Total Return to Investors (10 year, annualized)8.4%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Eli Lilly

Valeant's New CEO Joe Papa Has a $17 Billion Ultimatum

If he pulls it off, he will make more than all of his peers combined.

Read More →
A Pharma CEO Says What Few Will

Should a drug company spend billions trying to innovate…or simply shop around for good ideas?

Read More →
Another Failure in Alzheimer’s. Another Shrug.

Merck halts a major high-hopes late-stage drug trial. Join the club.

Read More →

Videos about Eli Lilly

Here’s Why So Many Pharma Giants Are Cutting Jobs

Mylan, Eli Lilly, Endo, AstraZeneca, and Sanofi announced the layoffs over the past week.

Read More →